NO313402B1 - Anthelmintisk sammensetning, tablett samt fremgangsmate ved fremstilling derav - Google Patents
Anthelmintisk sammensetning, tablett samt fremgangsmate ved fremstilling derav Download PDFInfo
- Publication number
- NO313402B1 NO313402B1 NO19964912A NO964912A NO313402B1 NO 313402 B1 NO313402 B1 NO 313402B1 NO 19964912 A NO19964912 A NO 19964912A NO 964912 A NO964912 A NO 964912A NO 313402 B1 NO313402 B1 NO 313402B1
- Authority
- NO
- Norway
- Prior art keywords
- composition
- dogs
- flubendazole
- weight
- tablets
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 230000000507 anthelmentic effect Effects 0.000 title claims abstract description 4
- 238000000034 method Methods 0.000 title description 6
- 238000002360 preparation method Methods 0.000 title description 3
- 241000282472 Canis lupus familiaris Species 0.000 claims abstract description 24
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960004500 flubendazole Drugs 0.000 claims abstract description 16
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 208000006968 Helminthiasis Diseases 0.000 claims abstract description 5
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 claims abstract description 5
- 239000003826 tablet Substances 0.000 claims description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 14
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 14
- 239000007910 chewable tablet Substances 0.000 claims description 8
- 229940068682 chewable tablet Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 8
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 8
- 229960003943 hypromellose Drugs 0.000 description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 239000008108 microcrystalline cellulose Substances 0.000 description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- 229920002785 Croscarmellose sodium Polymers 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- -1 rice Chemical compound 0.000 description 4
- 208000035404 Autolysis Diseases 0.000 description 3
- 206010057248 Cell death Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 229960001681 croscarmellose sodium Drugs 0.000 description 3
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000028043 self proteolysis Effects 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001719 carbohydrate derivatives Chemical group 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229920003125 hypromellose 2910 Polymers 0.000 description 2
- 229940031672 hypromellose 2910 Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
- A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fodder In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94201434 | 1994-05-20 | ||
| PCT/EP1995/001801 WO1995031963A1 (fr) | 1994-05-20 | 1995-05-12 | Tablettes de flubendazole a mastiquer pour animaux de compagnie |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO964912L NO964912L (no) | 1996-11-19 |
| NO964912D0 NO964912D0 (no) | 1996-11-19 |
| NO313402B1 true NO313402B1 (no) | 2002-09-30 |
Family
ID=8216895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19964912A NO313402B1 (no) | 1994-05-20 | 1996-11-19 | Anthelmintisk sammensetning, tablett samt fremgangsmate ved fremstilling derav |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5824336A (fr) |
| EP (1) | EP0760648B1 (fr) |
| JP (1) | JPH10501211A (fr) |
| AT (1) | ATE208611T1 (fr) |
| AU (1) | AU690994B2 (fr) |
| BR (1) | BR9507637A (fr) |
| CA (1) | CA2190357C (fr) |
| CY (1) | CY2255B1 (fr) |
| CZ (1) | CZ290406B6 (fr) |
| DE (1) | DE69523912T2 (fr) |
| DK (1) | DK0760648T3 (fr) |
| ES (1) | ES2167436T3 (fr) |
| FI (1) | FI118324B (fr) |
| HK (1) | HK1010695A1 (fr) |
| HU (1) | HU225958B1 (fr) |
| IL (1) | IL113782A (fr) |
| NO (1) | NO313402B1 (fr) |
| NZ (1) | NZ285766A (fr) |
| PL (1) | PL185332B1 (fr) |
| PT (1) | PT760648E (fr) |
| SI (1) | SI0760648T1 (fr) |
| WO (1) | WO1995031963A1 (fr) |
| ZA (1) | ZA954128B (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2317560A (en) * | 1996-09-20 | 1998-04-01 | Edmund John Hilary Campion | Anti-parasite medication for pets |
| WO2001021178A2 (fr) * | 1999-09-22 | 2001-03-29 | Akzo Nobel, N.V. | Procede destine a traiter le syndrome de dysfonctionnement cognitif chez le chien et comprimes a croquer pour chiens |
| DE10031044A1 (de) * | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
| US20050271708A1 (en) * | 2002-03-05 | 2005-12-08 | Thombre Avinash G | Palatable controlled-release formulation for companion animals |
| US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
| CO5400144A1 (es) * | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
| US20040151759A1 (en) * | 2002-08-16 | 2004-08-05 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| EP1759692A3 (fr) * | 2003-03-10 | 2007-09-12 | Novartis AG | Compositions solides veterinaires à goût masqué |
| GB2399752A (en) * | 2003-03-26 | 2004-09-29 | Micap Plc | Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant |
| AR045142A1 (es) | 2003-07-30 | 2005-10-19 | Novartis Ag | Composicion veterinaria masticable ductil de buen sabor |
| CZ17621U1 (cs) | 2003-08-26 | 2007-06-25 | Shire Holdings Ag | Farmaceutický prostredek zahrnující slouceniny lanthanu |
| US7381428B2 (en) * | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
| DE102004011512B4 (de) * | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische Zubereitung enthaltend Pimobendan |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1579862A1 (fr) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques |
| US7348027B2 (en) * | 2005-04-08 | 2008-03-25 | Bayer Healthcare Llc | Taste masked veterinary formulation |
| EP1920785A1 (fr) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine |
| WO2010132286A1 (fr) * | 2009-05-12 | 2010-11-18 | Wyeth Llc | Préparation en comprimé administrée par voie orale d'un composé antianxiolytique |
| AU2013217633B2 (en) | 2012-02-06 | 2017-01-12 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
| ES2924478T3 (es) | 2012-03-15 | 2022-10-07 | Boehringer Ingelheim Vetmedica Gmbh | Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos |
| AU2013245011B2 (en) | 2012-04-04 | 2017-11-23 | Intervet International B.V. | Solid oral pharmaceutical compositions for isoxazoline compounds |
| BR112015023435B1 (pt) | 2013-03-15 | 2022-05-03 | Douglas Robert Cleverly | Formulação mastigável estável sob armazenagem e método de fabricação de uma formulação mastigável, palatável e estável sob armazenagem |
| CN113181110A (zh) | 2013-07-19 | 2021-07-30 | 勃林格殷格翰动物保健有限公司 | 含有防腐的醚化的环糊精衍生物的液体水性药物组合物 |
| JP6117079B2 (ja) * | 2013-10-01 | 2017-04-19 | 富士フイルム株式会社 | チュアブル錠用組成物及びチュアブル錠 |
| US20150164047A1 (en) * | 2013-11-07 | 2015-06-18 | Urban Pet Haus, LLC | Edible cat toy |
| WO2015082389A1 (fr) | 2013-12-04 | 2015-06-11 | Boehringer Ingelheim Vetmedica Gmbh | Compositions pharmaceutiques améliorées de pimobendan |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE944581C (de) * | 1953-10-15 | 1956-06-21 | Waldhof Zellstoff Fab | Verfahren zur Herstellung einer Pilengrundmasse |
| AU5957480A (en) * | 1979-07-26 | 1981-01-29 | American Cyanamid Company | Diethyl carbamazine resinate |
| US4578268A (en) * | 1979-07-26 | 1986-03-25 | American Cyanamid Company | Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals |
| JPS5821615A (ja) * | 1981-07-29 | 1983-02-08 | Fujisawa Pharmaceut Co Ltd | 草食獣の肝蛭症の予防治療剤 |
| DE3705227A1 (de) * | 1987-02-19 | 1988-09-01 | Bayer Ag | Anthelminthische wirkstoffkombinationen |
| FR2623976B1 (fr) * | 1987-12-08 | 1994-02-25 | So Ge Val | Comprime pour animal domestique |
-
1995
- 1995-05-12 DE DE69523912T patent/DE69523912T2/de not_active Expired - Lifetime
- 1995-05-12 AU AU25272/95A patent/AU690994B2/en not_active Ceased
- 1995-05-12 NZ NZ285766A patent/NZ285766A/en not_active IP Right Cessation
- 1995-05-12 HU HU9603215A patent/HU225958B1/hu not_active IP Right Cessation
- 1995-05-12 AT AT95919448T patent/ATE208611T1/de active
- 1995-05-12 JP JP7530026A patent/JPH10501211A/ja active Pending
- 1995-05-12 SI SI9530557T patent/SI0760648T1/xx unknown
- 1995-05-12 WO PCT/EP1995/001801 patent/WO1995031963A1/fr active IP Right Grant
- 1995-05-12 PT PT95919448T patent/PT760648E/pt unknown
- 1995-05-12 CA CA002190357A patent/CA2190357C/fr not_active Expired - Fee Related
- 1995-05-12 US US08/732,263 patent/US5824336A/en not_active Expired - Lifetime
- 1995-05-12 CZ CZ19963335A patent/CZ290406B6/cs not_active IP Right Cessation
- 1995-05-12 ES ES95919448T patent/ES2167436T3/es not_active Expired - Lifetime
- 1995-05-12 DK DK95919448T patent/DK0760648T3/da active
- 1995-05-12 EP EP95919448A patent/EP0760648B1/fr not_active Expired - Lifetime
- 1995-05-12 PL PL95317227A patent/PL185332B1/pl not_active IP Right Cessation
- 1995-05-12 BR BR9507637A patent/BR9507637A/pt not_active IP Right Cessation
- 1995-05-18 IL IL11378295A patent/IL113782A/xx not_active IP Right Cessation
- 1995-05-19 ZA ZA954128A patent/ZA954128B/xx unknown
-
1996
- 1996-11-19 FI FI964623A patent/FI118324B/fi not_active IP Right Cessation
- 1996-11-19 NO NO19964912A patent/NO313402B1/no not_active IP Right Cessation
-
1998
- 1998-10-30 HK HK98111640A patent/HK1010695A1/xx not_active IP Right Cessation
-
2002
- 2002-01-04 CY CY0200003A patent/CY2255B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI964623A (fi) | 1996-11-19 |
| WO1995031963A1 (fr) | 1995-11-30 |
| PT760648E (pt) | 2002-04-29 |
| FI964623A0 (fi) | 1996-11-19 |
| AU690994B2 (en) | 1998-05-07 |
| CY2255B1 (en) | 2003-07-04 |
| NO964912L (no) | 1996-11-19 |
| JPH10501211A (ja) | 1998-02-03 |
| PL317227A1 (en) | 1997-03-17 |
| ES2167436T3 (es) | 2002-05-16 |
| ZA954128B (en) | 1996-11-19 |
| DE69523912D1 (de) | 2001-12-20 |
| CA2190357A1 (fr) | 1995-11-30 |
| HU225958B1 (en) | 2008-01-28 |
| BR9507637A (pt) | 1997-10-07 |
| DK0760648T3 (da) | 2002-02-25 |
| CA2190357C (fr) | 2007-04-17 |
| NZ285766A (en) | 1997-09-22 |
| PL185332B1 (pl) | 2003-04-30 |
| CZ290406B6 (cs) | 2002-07-17 |
| FI118324B (fi) | 2007-10-15 |
| US5824336A (en) | 1998-10-20 |
| AU2527295A (en) | 1995-12-18 |
| IL113782A (en) | 1999-08-17 |
| HK1010695A1 (en) | 1999-06-25 |
| HU9603215D0 (en) | 1997-01-28 |
| CZ333596A3 (en) | 1997-02-12 |
| ATE208611T1 (de) | 2001-11-15 |
| EP0760648B1 (fr) | 2001-11-14 |
| IL113782A0 (en) | 1995-08-31 |
| NO964912D0 (no) | 1996-11-19 |
| HUT74988A (en) | 1997-03-28 |
| DE69523912T2 (de) | 2002-06-27 |
| SI0760648T1 (en) | 2002-04-30 |
| EP0760648A1 (fr) | 1997-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO313402B1 (no) | Anthelmintisk sammensetning, tablett samt fremgangsmate ved fremstilling derav | |
| AU2018316531B2 (en) | Oral compositions and the preparation methods thereof | |
| EP1886665A1 (fr) | Système thérapeutique gastro-retentif | |
| US4283400A (en) | Medicated animal feed based on liver meal | |
| TW201103439A (en) | Coccidiosis control agent and feed containing same | |
| NZ760233A (en) | Compositions and methods for treatment of abnormal cell growth | |
| US2893914A (en) | Thiadicarbocyanine anthelmintic compositions and methods of using them | |
| JPS6114124B2 (fr) | ||
| KR20180087114A (ko) | 모사프리드 또는 이의 염을 포함하는 약제학적 제제 및 이의 제조방법 | |
| JPS6412248B2 (fr) | ||
| KR20140096431A (ko) | 모넨신을 주성분으로 하는 가축의 콕시듐증 예방용 펠릿형 조성물 및 그의 제조방법 | |
| CN102552292A (zh) | 一种阿仑膦酸钠维生素d3药物制剂 | |
| KR100944121B1 (ko) | 콩 다당체를 포함하는 속효성이 향상된 약제학적 조성물 | |
| CN101664470A (zh) | 一种防治畜禽腹泻的药物组合物及其应用 | |
| CN108463216B (zh) | 口腔内保持型崩解性固体制剂、其制造方法和用于该制造方法的粉体组合物 | |
| JPH02311421A (ja) | 高尿酸血症改善剤及び改善用食品 | |
| JP2799273B2 (ja) | 動物の成長促進方法及びクロストリジウム属菌死菌体粉末製剤 | |
| JP2987359B2 (ja) | 動物の成長促進方法及びクロストリジウム属菌死菌体粉末製剤 | |
| JP2016190793A (ja) | 錠剤およびその製造方法 | |
| JP2933241B2 (ja) | 免疫賦活方法及び免疫賦活剤 | |
| KR20070119297A (ko) | 속효성이 증진된 나테글리니드를 유효성분으로 함유하는약제학적 조성물 | |
| CN102379938B (zh) | 一种兽用中西复方退热药物组合物 | |
| JPH0977683A (ja) | 動物における生産促進剤としてのバルヒマイシンの使用および生産促進剤組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA |
|
| MM1K | Lapsed by not paying the annual fees |